Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors
Kallyope, a clinical-stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with […]
Marie Mazur Appointed Chair of PharmaJet Board of Directors
PharmaJet, a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals […]
Visgenx Appoints William Pedranti as Chief Executive Officer
Visgenx, a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced […]
The OSE Immunotherapeutics Board of Directors Proposes the Appointment of Eric Leire, MD, as New Independent Director
OSE Immunotherapeutics, a biotech company dedicated to developing first-in-class assets in immuno-oncology and immuno-inflammation, today […]
Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors
Acurex Biosciences, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces […]
TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors
TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]
FzioMed Announces Addition of Industry Veteran to its Board of Directors
FzioMed, a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, […]
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
Prothena, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on […]
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of […]
NeuroBo Pharmaceuticals Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more